Article Text
PDF
Other content recommended for you
- Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report
- Asymmetry in Scientific Method and Limits to Cross-Disciplinary Dialogue
- Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case–control study protocol for dimethyl fumarate-induced lymphopenia
- Essential(ist) medicine: promoting social explanations for racial variation in biomedical research
- Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementation
- Paediatric pharmacogenomics: an overview
- Fifteen-minute consultation: Pharmacogenomics: a guide for busy clinicians
- The patient who reports a drug allergy
- Introduction to pharmacogenetics
- Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol